Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 4/20 | 1.00 |
| ▸ | SI | P14410 | 2/20 | 1.00 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.52 |
| ▸ | GLB1 | P16278 | 2/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | CDA | P32320 | 1/20 | 0.40 |
| ▸ | TREH | O43280 | 1/20 | 0.38 |
| ▸ | AHCY | P23526 | 3/20 | 0.36 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valienamine SCHEMBL3960550 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14408654 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14409002 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14408836 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14416123 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14408647 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14193749 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14408472 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL12955939 | 1.00 | MGAM (1.00) | MGAMSIFUCA1GLB1GBA1 | |
| Valienamine SCHEMBL14408468 | 0.85 | MGAM (0.73) | MGAMSIFUCA1GLB1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4463445-B1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED ?-GALACTOSIDASE ACTIVITY | DORPHAN S A (CH) | 2025-10-01 | — | — | EP | claimed |
| CN-119677539-A | Combination therapy for modulating lipid production | 俄亥俄州创新基金会 | 2025-03-21 | — | — | CN | claimed |
| CN-118786120-A | Compounds and their use for the treatment of diseases associated with impaired beta-galactosidase activity | 多尔潘股份公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118000046-B | Organic plant nutrient soil and preparation method thereof | 宁夏大彩生物科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2023172669-A9 | COMBINATION THERAPIES FOR MODULATION OF LIPID PRODUCTION | OHIO STATE INNOVATION FOUNDATION (US) | 2024-08-02 | — | — | WO | claimed |
| CN-118000046-A | Organic plant nutrient soil and preparation method thereof | 宁夏大彩生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-114908130-B | Method for preparing aminosugar intermediate valienamine by enzyme method and application thereof | 上海凡秦医药科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117298177-B | Natural immunomodulator and preparation method thereof | 暨南大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117298177-A | Natural immunomodulator and preparation method thereof | 暨南大学 | 2023-12-29 | — | — | CN | claimed |
| WO-2023172669-A2 | COMBINATION THERAPIES FOR MODULATION OF LIPID PRODUCTION | OHIO STATE INNOVATION FOUNDATION (US) | 2023-09-14 | — | — | WO | claimed |
| EP-1009398-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | Yu, Ruey J., Dr. (US) | 2000-06-21 | — | — | EP | claimed |
| WO-2000018949-A2 | DELIVERY OF PHOSPHOINOSITIDE POLYPHOSPHATES INTO CELLS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-04-06 | — | — | WO | claimed |
| US-5929037-A | GLUCOSIDASE I INHIBITORS | ALBERTA RESEARCH COUNCIL (CA) | 1999-07-27 | — | — | US | claimed |
| US-5877212-A | HYDROGEN BONDING WITH COMPLEXING AGENT | YU RUEY J (US) | 1999-03-02 | — | — | US | claimed |
| WO-1998046217-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0837867-A1 | MODIFIED $g(a)-D-Glcp-(1-2)-$g(a)-D-Glcp-(1-3)-$g(a)-D-Glcp-ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1998-04-29 | — | — | EP | claimed |
| WO-1996040700-A1 | MODIFIED α-D-Glcp-(1-2)-α-D-Glcp-(1-3)-α-D-Glcp-ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1996-12-19 | — | — | WO | claimed |
| US-5169767-A | Culture product of Sclerotium promoted by validamycin | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-12-08 | — | — | US | claimed |
| EP-0049981-B1 | VALIENAMINE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-07-25 | — | — | EP | claimed |
| EP-0049981-A1 | Valienamine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1982-04-21 | — | — | EP | claimed |